![Figure 1 (spheroid): Rapid volumetric imaging of a densely labelled spheroid microtissue at isotropic resolution followed by 3D object segmentation allows for accurate quantification and localization of cell populations in three-dimensional samples.]({"xsmall":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.100.33.0,1158,11413,4959.file/aacr-backwall.png","small":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.360.120.0,1158,11413,4959.file/aacr-backwall.png","medium":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.768.256.0,1158,11413,4959.file/aacr-backwall.png","large":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.1024.341.0,1158,11413,4959.file/aacr-backwall.png","xlarge":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.1280.427.0,1158,11413,4959.file/aacr-backwall.png","xxlarge":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.1440.480.0,1158,11413,4959.file/aacr-backwall.png","max":"https://www.zeiss.com/content/dam/rms/countries/united-states/events/aacr-2026/aacr-backwall.png/_jcr_content/renditions/original.image_file.1920.640.0,1158,11413,4959.file/aacr-backwall.png"} "Figure 1 (spheroid): Rapid volumetric imaging of a densely labelled spheroid microtissue at isotropic resolution followed by 3D object segmentation allows for accurate quantification and localization of cell populations in three-dimensional samples.")
ZEISS @ American Association for Cancer Research (AACR) Annual Meeting 2026
April 17-22 | Booth #3126Join ZEISS @ AACR 2026
Join ZEISS at AACR 2026 at Booth #3126, where we’ll be showcasing advanced imaging solutions designed to accelerate cancer research. From organoids and organ-on-chip models to spatial biology and translational cancer studies, our experts will be on hand to discuss how cutting-edge microscopy and analytical tools can help you generate deeper biological insight and drive more confident discoveries.
What's New at ZEISS @ AACR 2026?
New frontiers in cancer research and discoverySpatial Biology imaging workflow
Workflow automation at scaleSpatial biology is increasingly central to understanding mechanism of action, target engagement, and cellular interactions within complex biological systems. ZEISS spatial biology workflows support multiplexed imaging and quantitative analysis while maintaining consistency and reproducibility across experiments. Designed for translational and high-content environments, these workflows integrate automation and analysis to help teams move from rich spatial data to actionable insight—without sacrificing biological context.
Imaging & analysis workflows for new approach methodologies (NAMs)
Supporting human-relevant models with scalable measurement.New approach methodologies such as organ-on-chip systems and advanced 3D cultures promise improved human relevance in drug discovery—but only when paired with robust, quantitative readouts. ZEISS imaging and analysis workflows are designed to support NAM adoption by enabling consistent measurement across large, multidimensional microscopy datasets. At AACR, ZEISS is highlighting how integrated imaging and analysis help bridge innovative model systems with reproducible, decision-ready data.
![Microscopy services for biotech, life science, and materials science]({"xsmall":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.100.56.file/zeiss-biotech-pharma-stage.jpg","small":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.360.203.file/zeiss-biotech-pharma-stage.jpg","medium":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.768.432.file/zeiss-biotech-pharma-stage.jpg","large":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.1024.576.file/zeiss-biotech-pharma-stage.jpg","xlarge":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.1280.720.file/zeiss-biotech-pharma-stage.jpg","xxlarge":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original.image_file.1440.810.file/zeiss-biotech-pharma-stage.jpg","max":"https://www.zeiss.com/content/dam/rms/reference-master/campaigns/sector-independent/fy-2526/biotech-pharma-solutions/zeiss-biotech-pharma-stage.jpg/_jcr_content/renditions/original./zeiss-biotech-pharma-stage.jpg"} "Microscopy services for biotech, life science, and materials science")
ZEISS Microscopy as a Service
Not every cancer research breakthrough requires new equipment.Whether you require tissue multiplexing, high content screening, 3D imaging, image analysis, or other imaging services that will advance your cancer research pipeline, save time and investment with ZEISS' flexible Microscopy as a Service.